Argent BioPharma

Finance

Cannabis Stock Roundup: Avecho Surpasses Enrolment Target, Argent Ships CannEpil to Ireland, Neurotech Addresses Funding Queries

April 29, 2026

Premium

Medical

Brief: Over 150 Candidates Vie for Council CEO Post; Rua Exports NZ Cannabis Genetics to Canada; Argent Closes CannPal Stake Purchase

April 15, 2026

Finance

Company Roundup: Avecho, InhaleRx, Neurotech, Peak, Zelira, Argent

February 02, 2026

Finance

Argent BioPharma signs binding deal to take AusCann's stake in CannPal

January 15, 2026

Premium

Finance

Argent BioPharma Locks In A$11m Funding Deal to Finalise AusCann Buy and Pursue US Listing

November 17, 2025

Finance

Argent BioPharma strikes binding deal to take on AusCann's assets and intellectual property

August 19, 2025

Medical

Althea winds down Australian operations after asset sale; Argent Biopharma launches clinical supply in Slovenia; ECS Botanics supports UWA sleep apnoea study

July 08, 2025

Medical

Argent Biopharma and Auscann Strike Agreement to Advance Cannabinoid Drug Development

April 23, 2025

Medical

TGA eyes paediatric cannabis rule change; Germany keeps legalisation; Argent strikes Malta agreement; Kylie O'Brien joins Cann Compounding

April 10, 2025

Finance

Brief: Rua faces German supply crunch; Zelira secures equity line; Queensland grower raises $1.4m; Neurotech director exits; CannEpil wins German approval; Cann Group inks Chemist Warehouse deal

April 03, 2025

Finance

Corporate Updates: Argent BioPharma Raises $7.3m; Greenfern Industries Secures Loan

January 13, 2025

Premium

Finance

Half-Year and Full-Year Financial Roundup: Rua Bioscience, Elixinol Wellness, Argent Biopharma, Wellnex Life, InhaleRx, Bioxyne

September 02, 2024

Premium

Finance

Argent BioPharma Moves to Exit ASX Amid Thin Trading and Weak Investor Appetite

August 15, 2024

Finance

Zelira Therapeutics Shares Jump 60% on Patent Win; Argent Biopharma Completes Second Capital Raise

July 16, 2024

Finance

Industry Updates: Zelira Therapeutics, Ecofibre, Cann Group, InhaleRx, Argent Biopharma, Melodiol Global Health, Wellnex Life

July 04, 2024

Premium

Finance

Q3 and Q1 FY24 Financial Roundup: Bioxyne, Melodiol Global Health, Emyria, Zelira, Elixinol, Wellnex Life, and Argent BioPharma

May 01, 2024

Finance

Industry Roundup: Bioxyne/BLS, Rua Bioscience, Botanix, Melodiol Global Health, Zelira, Argent BioPharma

April 16, 2024

Medical

MGC Pharmaceuticals Rebrands as Argent BioPharma on ASX

April 02, 2024